The importance of maintaining a patient's core body temperature during anaesthesia to reduce the incidence of postoperative complications has been well documented. The standard practice of this institution is the use of a forced air device for intraoperative warming. The purpose of this study was to compare this standard with an alternative warming device using a radiant heat source which only heated the face.
Patients undergoing surgery while under a general anaesthetic are at risk of perioperative hypothermia 1, 2 . Hypothermia can increase the likelihood of wound infection and morbidity and prolong recovery 3 . Without active warming, a patient's core temperature can potentially decrease by 1 to 1.5°C in the first hour after induction 1, 2 . It has also been demonstrated that patients undergoing laparoscopic cholecystectomy develop a significant drop in core temperature (below 36.0°C) if no active warming is used 4 . It has been shown that patients under-going laparoscopic cholecystectomy lose as much heat from their core as those patients during open cholecystectomy 5 .
To minimize hypothermia, active warming is utilized in the operating rooms at Middlemore Hospital. Currently the most common method is the use of a forced air device in the form of an inflatable paper blanket, placed in direct contact with the patient's skin, the BairHugger™ model 505 (Augustine Medical, U.S.A.). Of the many other intraoperative warming devices which are available, forced air warmers have been shown to be the most practical and effective, to date 6 .
Whilst forced air devices are effective in preventing mild hypothermia during general anaesthesia in the operating theatre, there are some inherent problems with this method. There is significant cost associated with the single patient use blanket, often precluding its use for shorter surgical operations where net heat loss and core hypothermia can occur, even after one hour 7 .
An alternative method of maintaining normother-mia during surgery is by means of a radiant warming device, SunTouch™ model PW820 (Fisher & Paykel Healthcare, N.Z.). Placed above the patient's face, hand or feet, this device is free standing and doubles as an IV pole.
To date, there have been no randomized trials published comparing these two methods of intraoperative warming.
This study was undertaken to assess the efficacy of this new radiant warming device in maintaining intraoperative normothermia using our usual forced air warmer as the control.
MATERIALS AND METHODS

Patients
With approval of the Local District Ethics Committee, female patients attending Middlemore Hospital for laparoscopic cholecystectomy were approached upon admission for inclusion in the trial. Inclusion criteria included those who were 20 to 60 years of age, with weight between 50 and 110 kg. Patients were excluded from the trial if they presented with pre-existing hyperpyrexia, had a history of malignant hyperthermia, or were currently taking antipyretic medication.
Once written informed consent was obtained in the ward, the patients were allocated randomly, utilizing random number tables (with even numbers allocated to forced air warming), to either the upper body forced air warming blanket (control) or the trial radiant warming device. Once in the operating room patients were placed supine on the operating table with arms extended to 90° on armrests. Thin hospital blankets were placed, covering their torso, arms and legs. Draping procedure followed the usual protocol for laparoscopic cholecystectomy operations performed in this hospital.
Sample size calculations (see below) suggested that a minimum of 20 patients were required in each group.
Warming devices
In the group that received forced air warming an upper body blanket (model 522 BairHugger™ Augustine Medical, U.S.A.) was used. This was placed against the skin over the arms, upper body and head according to manufacturer's instructions. The warmer was switched to its highest setting (43°C) after the operating theatre drapes had been applied, consistent with current theatre protocol and as has been previously well described 8 .
If the patient was randomized to the radiant warming group, the warmer was positioned directly over the patient's face. The warmer's skin temperature sensor was taped to the forehead using Micropore™ tape and the maximum skin temperature setting on the warmer was set to 41°C ( Figure 1 ).
The radiant warmer utilizes infrared B energy to warm the patient. This energy is evenly applied over an area of 20 cm x 30 cm with an energy intensity of 100mW/cm 2 with the heater 40 cm above the patient. The patient's skin temperature is monitored using a skin temperature sensor that is positioned in the centre of the warmer's irradiance field, indicated by the point of two converging indicator light beams, which also indicate the correct skin-to-heater height. An ultrasonic height sensing system ensures that the heater power is reduced if the radiant warmer is placed too close to the patient.
A microprocessor within the warmer checks the patient's skin temperature via a skin temperature sensor, several times a second. This regulates the heater power to maintain the patient's skin temperature to a level set by the user, usually 37 to 41°C. The skin temperature sensor also contains a radiant power monitor to ensure that the sensor is placed directly beneath the heater. A series of alarms monitor skin temperature and activate if the sensor is not attached to the skin beneath the heater, or if the skin temperature is too high or low.
This radiant device heats only a small area of the patient, utilizing areas high in arteriovenous anastomoses such as the forehead, nose, ears, hands and feet 9 . It is known that these anastomoses dilate to increase arteriovenous blood flow by as much as 40 times 10 to provide thermoregulation and in particular cooling of the blood by allowing large volumes of blood to pass close to the surface of the skin 11 . These anastomoses can also dilate in response to local heating 12 and anaesthesia 13 and allow applied heat energy to be transferred directly to the core via the circulation.
Anaesthetic
In both groups a standardized anaesthetic was given. Induction was performed using propofol 2 to 4 mg/kg with fentanyl 1 to 2 µg/kg. Muscle relaxation was achieved with rocuronium 0.5-0.75 mg/kg prior to intubation. Patients were ventilated to maintain an end-tidal CO 2 of between 35 and 45 mmHg using a single use circle circuit (RT117 Fisher and Paykel Healthcare, N.Z.) with a standard bacterial filter (Hygrobac "S" D.A.R, Italy).
Anaesthesia was maintained using isoflurane, nitrous oxide (70%) and oxygen (30%) at gas flows of approximately 1.0 l/min. Each patient received one litre of IV fluid pre-warmed to 42°C. Neostigmine 0.05-0.07 mg/kg with atropine 0.01-0.03 mg/kg was used for reversal of neuromuscular blockade.
Temperature recording
During the patient preparation in theatre after induction, 30 cm depth distal oesophageal and 5 cm depth nasopharyngeal probes (GP9400 Coast Medical Inc, U.S.A.) were inserted. These temperature sensors were connected to a 12 bit analogue to digital card (DAQ 700, National Instruments, U.S.A.) and logged at 10 second intervals from an average sampled at 10 Hz to a laptop computer once the heating device was switched on. The computer stored the measured data in a Paradox 5 database.
Oesophageal temperature is regarded as one of the best indictors of true core temperature 14, 15 and was used for the final analysis of patients' core temperature. Nasopharyngeal temperatures were recorded for two reasons: firstly, to ascertain whether the nasopharyngeal temperature is affected by the radiant warmer heating the face, and secondly, to define the difference between the distal oesophageal and nasopharyngeal temperatures, (nasopharyngeal temperature being the most commonly used surgical core temperature measurement in practice due to its practicality in application).
Operating theatre temperature and humidity were also recorded using a temperature/humidity meter (HM34 Vaisala Finland).
Following the completion of surgery, the method of warming was discontinued and the patient transferred to the recovery room. While in recovery, axillary temperatures (digital thermometer, Becton Dickinson, U.S.A.) were recorded every ten minutes until discharge to the ward. Time spent in the recovery department was also documented.
Statistics
The data was analysed within Microsoft Excel™ using a two-sample t-test assuming equal variances. Values are expressed as mean (standard deviation). between the start and end oesophageal temperatures in the two groups of 0.116, significance 0.05, power 80% and detectable difference 0.1°C. Therefore a minimum of 20 patients were required in each group.
RESULTS
A total of 42 female patients were recruited to participate in the study over a period of eighteen months, 21 randomized to the radiant warmer and 21 to the control (forced air) group.
The two study groups were well matched for age, duration of surgery, volume of "wash" fluid used, volume of CO 2 used for insufflation, IV fluid and length of stay in recovery. However, the group randomized to the radiant warmer had a slightly higher BMI than the forced air control group (P=0.015) (Table. 1).
Less than 10% (total of 4) of those patients approached either declined to participate or were excluded from the study. Of the exclusions, two were because of language difficulties, one case was due to conversion to an open procedure and one because of patient refusal to participate in the study.
Mean theatre temperature was 21.6°C (±1.1) for the radiant group and 22.2°C (±1.2) for the forced air group ( Figure 2 ) (P(T<=t) two-tail 0.098). Mean humidity was 46%RH (±4) radiant and 45%RH (±5) for forced air.
The mean distal oesophageal temperature following induction was 35.9°C (±0.5) for the radiant device and 36.1°C (±0.4) for the forced air group. On completion of surgery the mean oesophageal temperature was 36.0°C (±0.4) and 36.2°C (±0.4) respectively. There was no statistical significance between the two methods' ability to maintain core body temperature (P=0.42) ( Figure 3) .
The difference in mean oesophageal temperatures throughout the surgery is shown in Figure 4 . This shows a correlation between the forced air and radiant devices in the first 12 minutes after induction, then a difference of approximately 0.2°C between the mean oesophageal temperatures for the remainder of the operation, with the BairHugger™ having the higher mean.
Once transferred to the recovery room environment, there was no significant difference between the axillary temperature of the patients in the radiant warming group (36.1°C (±0.5)) and the forced air warming group (36.2°C (±0.5)); (P=0.54). Time spent in recovery was also the same for the two groups ( Table 1) . The difference between mean distal oesophageal and nasopharyngeal temperatures was 0.10°C for the radiant group and 0.22°C for the forced air group (P=0.54).
DISCUSSION
This study demonstrates that the SunTouch™ PW820 radiant warmer is as clinically effective as the 
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BairHugger™ 505 forced air warmer, in preventing excessive heat loss in anaesthetized patients during laparoscopic cholecystectomy. The data shows a 95% confidence interval that the observed oesophageal temperature difference of the radiant heater from the forced air heater is -0.28°C to 0.12°C, giving a 0.08°C lower result for the radiant warmer (Figure 4) .
Despite the statistical significance of the BMI between the two groups, the mean BMI difference between the two groups was small (31.3 kg/m 2 (±5.3) for the radiant warmer group vs 28.1 kg/m 2 (±3.9) for the forced air group).
Average percentage body fat was 39.37% for the radiant group and 34.56% for the forced air group. This difference is unlikely to be of clinical significance as previous morphometric studies have shown core temperature drop variations in the first hour of around 0.02-0.04°C/% body fat 16 . Since the difference in percentage body fat between the two groups was 4.8%, we would expect a difference in temperature drop of only 0.14°C in the first hour. During the second or linear phase of cooling there is even less of a correlation between percentage body fat and rate of core cooling 16 . Obese patients are more vasodilated preinduction and are thought to suffer less redistribution hypothermia on induction of anaesthesia 16 .
The non-significant difference between oesophageal and nasopharyngeal temperatures between the two study groups showed that radiant warming of the face did not affect nasopharyngeal temperature measurement to any significant degree. Nasopharyngeal temperature is routinely used as a convenient measure of core temperature during surgery.
Thermal injury to the eyes from overhead warming is often cited as a concern. However, the eye has one of the best blood flows in the body. In fact a primary role of the choroidal blood supply is the redistribution of heat (which is a by-product of light absorption in the retina) 17 . Unpublished tests using non-contact infra red thermometers show that corneal temperature remains at normal levels during radiant heating of the face due to absorption of the infrared and dispersion of the energy in the eyelid.
The measurement of axillary temperature in recovery is standard practice in this institution. Although some have suggested that this is not an accurate reflection of core temperature, we have included the measurements as they still provide a useful clinically relevant comparison between the two groups.
A number of warming techniques including radiant lamps have been used to heat patients intraoperatively. Previous radiant lamps used for patient warming have suffered from either uncontrolled heating, high levels of infrared A, non-focused or uneven heating. Furthermore, some previous units have been of unacceptable size. This has generally precluded the use of radiant warming in the operating room. Radiant warming has been effectively utilized for postoperative warming 18, 19 and has been the method of choice for thermoregulatory care for many years in neonatal care units 20 . Radiant warming is also being increasingly used in emergency departments and is standard equipment in some resuscitation rooms.
The radiant warmer used in this study overcomes the problems suffered by earlier radiant devices by the incorporation of several safety devices such as patient-to-heater distance monitoring and accurate skin temperature sensing and monitoring. These features have markedly improved the safety of this method of rewarming. The small size and IV pole mounted nature of the heater also means that it does not cause unnecessary clutter in the operating room.
The comparative advantages of these two warming methods can now be addressed with regard to practicality of use and overall cost to the theatre department. Without the need for a blanket, the radiant warming system can have lower operating costs. Blankets cost in the region of NZ$20 each with the blower unit costing around NZ$2500: the radiant warmer costs around NZ$6000. So the two devices will have the same cost to the hospital after around 170 operations (~one month in our institution), however the radiant warmer requires no further ongoing cost, although a single use skin temperature sensor is available if required. Power usage of the radiant warmer is around one half of the forced air warmer. This makes the radiant warmer more economically acceptable, especially for shorter procedures (i.e. less than one to two hours). Patients lose heat from their core rapidly following anaesthetic induction and even short operations, less than 30 minutes, can result in net heat loss and hypothermia 15 .
Due to the ability of this radiant device to be effective whilst heating only a small area (i.e. the face) there is less interference with the surgical field as the device can often be placed further away from the operative site than forced air warmers. There is also no unwanted airflow over the surgical site, which means that the device is especially suitable for plastic and orthopaedic surgery where infection control is of paramount concern. In some cases, such as burns surgery, radiant warmers are the only suitable choice in terms of rewarming. Burn patients, especially children, lose a larger amount of heat due to the lack of an insulating layer of skin and large exposed area, and most clinicians are aware of the high operating room temperatures normally required to reduce the radiant heat losses from these patients.
Whilst the face was the area heated in this study, it is possible that the hands and feet, which are other areas high in arteriovenous anastomoses, may also be suitable for heat transfer which would allow the device to be used in head and neck surgery. Further studies of a similar nature are being undertaken to assess the effectiveness of this device in heating the core via these other sites rich in arteriovenous anastomoses.
The radiant warmer is not without its disadvantages and may not be suitable for use in some patients. Patients with poor perfusion will be more difficult to heat as the reduced blood flow over the heated site means that less heat is able to be transferred back to the core. This may be an issue when heating the lower limbs of patients with peripheral vascular disease or during aortic cross-clamping in aortic surgery. It is also necessary to adjust the heater-skin distance if the operating table is raised or lowered, in order to maintain the correct heater-topatient distance.
In terms of comfort for the surgeons, it would have been useful to assess their thermal comfort score in the theatre. However, we did not receive any negative comments from any of the surgeons with regards to the use of the radiant warmer device. Furthermore, the drapes separate the heating field from the surgeon (Figure 1) , further limiting the transfer of heat to the operative site.
SUMMARY
It appears that radiant warming of the face during anaesthesia can be an effective way to prevent excessive heat loss in anaesthetized patients. The reduced running costs compared to forced air warmers makes this device an attractive alternative for active warming in the operating room.
